УКАЗАТЕЛЬ ЛИТЕРАТУРЫ

1. Абрамовских О.С.,Алехина К.А., Савочкина А.Ю. и др. Микробный пейзаж репродуктивного тракта женщин с папилломавирусной инфекцией // Вестник Челябинского государственного университета.

2. Апгар Б.С., Броцман Г.Л., Шпицер М. Клиническая кольпоскопия. Иллюстрированное руководство. / перевод с английского под общей редакцией В.Н. Прилепской. – М.: Практическая медицина, 2012.

3. Аполихина И.А., Денисова Е.Д. Папилломавирусная инфекция гениталий: актуальная проблема современной гинекологии и пути ее решения // Вопросы гинекологии, акушерства и перинатологии. 2007. Т. 6. № 6. С. 70–75.

4. Барышев В.В., Андреев В.Г., Попучиев В.В. и др. Современные аспекты изучения респираторного папилломатоза. Сибирский онкологический журнал. 2009 №5 (34): 67-72.

5. Воробцова И.Н., Тапильская Н.И., Петров Ю.В. и др.Инфицирование новорожденных вирусом папилломы человека. // Детские инфекции 2007 - Т6 №1

- с 28-30.

6. Кетлинский С.А., Симбирцев А.С. Цитокины. - Спб.: ООО «Издательство Фолиант», 2008.

7. Климова Р. Р., Малиновская В. В., Паршина О. В и др. Влияние вирусных инфекций на цитокиновый профиль у беременных женщин с отягощенным акушерским анамнезом и иммунокорригирующая терапия интерфероном альфа2b человека // Вопросы вирусологии. 2013. Т. 58. № 1. С. 18–23.

8. Козлова В.И., Пухнер А.Ф. Атлас вирусных, хламидийных заболеваний гениталий и цитопатологии. - М.: Авиценна. - ЮНИТИ. - 1996. - 207с.

9. Короленкова Л.И. Клинические и молекулярно-генетические основы предрака и ранних форм рака шейки матки:Автореф.дисс.докт.мед.наук.:14.01.12. Mосква: ФГБУ «РОНЦ им. Н.Н. Блохина» РАМН, 2013.с.50.

10. Короленкова Л.И., Брюзгин В.В. Клетки рака в цервикальных мазках у беременных - что делать? // Проблемы репродукции. 2011. № 2. С. 94–98.

11. Краснопольский В. И., Логутова Л. С., Серова О. Ф. и др. Возможности использованияцитологического метода исследования шейк и матки у беременных // Российский вестникакушера-гинеколога.

№ 3.С. 83–86.

12. Куевда Д.А., Шипулина О.Ю., Минкина Г.Н. и др. Современные требования к диагностике генитальной папилломавирусной инфекции: количественный подход // Тезисы науч. работ 2-го Всероссийского конгресса дерматовенерологов.Санкт-Петербург, 25–28 сентября 2007 г. – СПб., 2007. – С.134–135.

13. Лисичкина Ю.А. Клинико-морфологические критерии гиперпластических заболеваний шейки матки // Автореф. дис. ... канд. мед. наук : 14.00.01. - Бишкек: Кыргызско-российский славянский университет, 2005. С. 30.

14. Макаров О.В, Алешкина В.А. ,СавченкоТ.Н. и др. Инфекции в акушерстве и гинекологии, Москва, МЕДпресс-информ, 2009 г.-464 с.

15. Манухин И.Б., Минкина Г.Н. Проблемы и перспективы цервикального скрининга. // Акушерство и гинекология. 2006. С. (Прил.№1) 51–56.

16. Минкина Г.Н., Манухин И.Б., Франк Г.А. Предрак шейки матки. - М.: Аэрограф-Медиа, 2001.

17. Новиков А.И., Кононов А.В., Ваганова И.Г. Инфекции, передаваемые половым путем, и экзоцервикс. - М.: Медицина, 2002.

18. Останин А.А., Макагон А.В., Леплина О.Ю. Показатели иммунитета плода в ранней диагностике внутриутробной инфекции. // Медицинская иммунология. – 2001. – Т. 3, № 4. – С. 515-524.

19. Патология шейки и тела матки : руководство для врачей / под ред. Е. В. Коханевич. –Нежин : Гидромакс, 2009. – 350 с.

20. Подзолкова Н.М., Дамиров М.М., Кижаев Ю.Е. и др. Кольпоскопическое исследование у беременных (учебно-методическая разработка). – М:РМАПО, 2011 – 56 с.

21. Потапнев М.П. Цитокиновая сеть нейтрофилов при воспалении // Иммунология. 1995. № 4. С. 34–40.

22. Прилепская В.Н., Довлетханова Э.Р., Абакарова П.Р. Возможности терапии ВПЧ-ассоциированных заболеваний гениталий у женщин // Акушерство и гинекология. 2011. № 5. С. 123–128.

23. Прилепская В.Н., Костава М.Н., Назарова Н.М. и др. Эффективность применения Изопринозина при лечении вульводинии, обусловленной инфекционно-воспалительными процессами // Рус. мед. журн. ‒ 2009. ‒ Т. 17, № 16.

24. Прилепская В.Н., Роговская С.И. Возможности Изопринозина в лечении хронических цервицитов и вагинитов // Русский Медицинский Журнал. 2008. Т. 16. № 1. С. 5–9.

25. Роговская С.И. Папилломавирусная инфекция у женщин и патология шейки матки. Руководство для практ. врача. - М.: ГЭОТАР-Медиа, 2005.

26. Роговская С.И. Папилломавирусная инфекция. – 3-е изд., испр. и доп. – M.:ГЭОТАР-Медиа,2010 – 240 с.

27. Роговская С.И. Практическая кольпоскопия – 3 – е изд., испр. и доп. -– М.:ГЭОТАР-Медиа,2013. – 240 с.

28. Семена И.И. Папилломавирусная инфекция: Клинико-иммунологические особенности женщин и методы комбинированной терапии // Автореф. дис. ... канд. мед. наук : 14.00.11, 14.00.10. - Спб.: Военно-медицинская академия им. С.М. Кирова, 2005. С. 26.

29. Солдатский Ю.Л., Онуфриева Е.К., Стрыгина Ю.В. и др. Рецидивирующий респираторный папилломатоз: современное решение проблемы. Вестник оториноларингологии, 2009, №4. С. 66-71.

30. Телетаева Г.М. Цитокины и противоопухолевый иммунитет // Практическая онкология. 2007. Т. 8. № 1. С. 211– 218.

31. Телешева Л.Ф. Иммунологические факторы секретов репродуктивного тракта женщин // Автореф. дис. ... докт. мед. наук: 14.00.01. Челябинск: Челябинский государственный медицинский институт, 2000. С. 41.

32. Тирская Ю. И. Рудакова Е. Б. Шакина И. А. и др. Роль цервицитов в акушерско-гинекологической патологии// Лечащий врач №10, 2009.

33. Урманчеева А.Ф. Рак шейки матки и беременность // Практическая онкология. 2002. Т. 3. № 3. С. 183–193.

34. Урманчеева А.Ф., Ульрих Е.А. Опухоли женских половых органов и беременность. Пособие для врачей. / под ред. Э.К. Айламазяна. – СПб.: ООО “Издательство Н-Л,” 2011.

35. Фирченко С.В., Манухин И.Б., Минкина Г.Н., Фадеева Е.А. Расширенная биопсия шейки матки у беременных: преимущества и безопасность // Проблемы репродукции 2012. №1. С. 79-83.

36. Хофмейер Д.Ю., Нейлсон Д.П., Алфиревич З. и др.Кокрановское руководство: Беременность и роды/ Пер.

37. Цинзерлинг, В.А. Перинатальные инфекции (вопросы патогенеза, морфологической диагностики и клинико-морфологических сопоставлений). Руководство для врачей Текст. / В.А. Цинзерлинг, В.Ф. Мельникова. СПб: Сотис.

— 2002. - 352с.

38. Черешнев В.А., Гусев Е.И. Иммунология воспаления: роль цитокинов // Медицинская иммунология. 2001. Т. 3. № 3. С. 361–368.

39. Чистяков М.А. Патоморфология папилломавирусной инфекции в системе “мать-плацента-плод” // Автореф. дис. ... канд. мед. наук : 14.00.15. Москва: ГУ НИИ морфологии человека РАМН, 2008. С. 27.

40. Шаргородская А.В. Клинико-эпидемиологические особенности папилломавирусной инфекции у молодых женщин: Автореф.дисс.

…канд.мед.наук.:14.01.01. Mосква: ГБОУ ВПО МГМСУ имени А.И. Евдокимова МЗ РФ, 2013.С.24.

41. ACOG Practice Bulletin. Clinical Management Guidelines for Obstetrician- Gynecologists. Number 61, April 2005. Human papillomavirus. // Obstet. Gynecol. 2005. V. 105. № 4. P. 905–918.

42. Agorastos T., Miliaras D., Lambropoulos A. et al. Detection and typing of human papillomavirus DNA in uterine cervices with coexistent grade I and grade III

intraepithelial neoplasia: biologic progression or independent lesions? // Eur. J. Obstet. Gynecol. Reprod. Biol. 2005. V. 121. № 1. P. 99–103.

43. Alberico S., Pinzano R., Comar M. [Maternal-fetal transmission of human papillomavirus]. // Minerva Ginecol. 1996. V. 48. № 5. P. 199–204.

44. Al-Halal H., Kezouh A., Abenhaim H.A. Incidence and obstetrical outcomes of cervical intraepithelial neoplasia and cervical cancer in pregnancy: a population-based study on 8.8 million births. // Arch. Gynecol. Obstet. 2013. V. 287. № 2. P. 245–250.

45. Apgar B.S., Zoschnick L., Wright T.C. The 2001 Bethesda System terminology.

// Am. Fam. Physician. 2003. V. 68. № 10. P. 1992–1998.

46. Armbruster-Moraes E., Ioshimoto L.M., Leão E. et al. Presence of human papillomavirus DNA in amniotic fluids of pregnant women with cervical lesions.

47. Baldauf J.J., Dreyfus M., Ritter J. et al. Colposcopy and directed biopsy reliability during pregnancy: a cohort study. // Eur. J. Obstet. Gynecol. Reprod. Biol. 1995. V. 62. № 1. P. 31–6.

48. Behbakht K., Friedman J., Heimler I. et al. Role of the vaginal microbiological ecosystem and cytokine profile in the promotion of cervical dysplasia: a case-control study. // Infect. Dis. Obstet. Gynecol. 2002. V. 10. № 4. P. 181–186.

49. Benedet J.L., Selke P.A., Nickerson K.G. Colposcopic evaluation of abnormal Papanicolaou smears in pregnancy. // Am. J. Obstet. Gynecol. 1987. V. 157. № 4 Pt 1. P. 932–937.

50. Bezold G., Politch J.A., Kiviat N.B. et al Prevalence of sexually transmissible pathogens in semen from asymptomatic male infertility patients with and without leukocytospermia. // Fertil. Steril. 2007. V. 87. № 5. P. 1087–97.

51. Bielanski A. Disinfection procedures for controlling microorganisms in the semen and embryos of humans and farm animals. // Theriogenology. 2007. V. 68. №1.P. 1–22.

52. Bosch F.X. Human papillomavirus: science and technologies for the elimination of cervical cancer. Expert Opin Pharmacother. 2011. Oct №12(14). P. 2189-204.

53. Bosch F.X.,Broker T.R., Forman D. Comprehensive control of human papillomavirus infections and related diseases. ICO Monograph Comprehensive control

of human papillomavirus infections and related diseases in the central and Eastren Europe and Central Asia region Vaccine V. 31, Supp.7,2013.

54. Boulet, G. A.V., Horvath, C. A.J., Berghmans, S., Bogers, J. Human Papillomavirus in Cervical Cancer Screening: Important Role as Biomarker. -Cancer Epidemiol. Biomarkers Prev., 2008, V. P. 810-817.

55. Bouvard V., Baan R., Straif K. et al. A review of human carcinogens--Part B: biological agents // The lancet oncology. 2009. V. 10, № 4. P. 321–322.

56. Boyer S.N., Wazer D.E., Band V. E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway.

57. Brandtzaeg P., Pabst R. Let’s go mucosal: communication on slippery ground. // Trends Immunol. 2004. V. 25. № 11. P. 570–577.

58. Brismar Wendel S., Kaldensjo T., Peterson P. et al. Slumbering mucosal immune response in the cervix of human papillomavirus DNA-positive and -negative women. // Int. J. Oncol. 2010. V. 37. № 6. P. 1565–1573.

59. Broder S. From the National Institutes of Health. // JAMA. 1992. V. 267. № 14. P. 1892.

60. Broderick D., Matityahu D., Dudhbhai M. et al. Histologic and colposcopic correlates of ASCUS pap smears in pregnancy. // J. Low. Genit. Tract Dis. 2002. V. 6.

№ 2. P. 116–9.

61. Bruni L., Diaz M., Castellsague X. et al. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings.J Infect Dis. 2010 Dec 15 № 202(12). P.1789-1799.

62. Bunney M.H., Barr B.B., McLaren K. et al. Human papillomavirus type 5 and skin cancer in renal allograft recipients. // Lancet. 1987. V. 2. № 8551. P. 151–152.

63. Calinisan J.H., Chan S.R., King A. et al. Calinisan J.H. и др. Human papillomavirus and blastocyst apoptosis. // J. Assist. Reprod. Genet. 2002. V. 19. № 3. P. 132–136.

64. Cason J., Mant C.A. High-risk mucosal human papillomavirus infections during infancy & childhood. // J. Clin. Virol. 2005. V. 32 Suppl 1. P. S52–58.

65. Cason J., Rice P., Best J.M. Transmission of cervical cancer-associated human papilloma viruses from mother to child. // Intervirology.1998.V. 41. № 4-5. P. 213–218.

66. Clerici M^., Merola M., Ferrario E. et al. Cytokine production patterns in cervical

intraepithelial neoplasia: association with human papillomavirus infection. // J. Natl. Cancer Inst. 1997. V. 89. № 3. P. 245–50.

67. Cohen E., Levy A., Holcberg G. et al. Perinatal outcomes in condyloma acuminata pregnancies. // Arch. Gynecol. Obstet. 2011.V. 283. № 6. P. 1269–73.

68. Constandinou-Williams C., Stuart I.Collins, Roberts S. et al. Is Human Papillomavirus Viral Load a Clinically Useful. Predictive Marker? A Longitudinal Study // Cancer Epidemiol Biomarkers Prev. 2010.V.19. P. 832–837.

69. Creasman W.T. Cancer and pregnancy.// Ann. N.Y. Acad. Sci. 2001.V. 943. P. 281–286.

70. Derkay C.S., Wiatrak B. Recurrent respiratory papillomatosis: a review. // Laryngoscope. 2008. V. 118. № 7. P. 1236–1247.

71. Didelot-Rousseau M.N., Diafouka F., Yayo E. et al. HPV seminal shedding among men seeking fertility evaluation in Abidjan, Ivory Coast. // J.Clin.Virol. 2007. V. 39. № 2. P. 153–155.

72. DiPaolo J.A., Woodworth C.D., Popescu N.C. et al. HSV-2-induced tumorigenicity in HPV16-immortalized human genital keratinocytes. // Virology. 1990. V. 177. № 2. P. 777–779.

73. DiSaia P.J., Creasman W.T. Clinical Gynecologic Oncology, Eighth Edition. Philadelphia, PA: Saunders Elsevier Inc., 2012 – 720 p.

74. Doerfler D., Bernhaus A., Kottmel A. et al. Human papilloma virus infection prior to coitarche. // Am. J. Obstet. Gynecol. 2009. V. 200. № 5. P. 487.e1–5.

75. Economos K., Perez Veridiano N., Delke I. et al. Abnormal cervical cytology in pregnancy: a 17-year experience. // Obstet. Gynecol. 1993. V. 81. № 6. P. 915–918.

76. Fader A.N., Alward E.K., Niederhauser A. et al. Cervical dysplasia in pregnancy: a multi-institutional evaluation //Am. J. Obstet. Gynecol.‒2010. – V. 203, № 2.– P. 113; e1‒6.

77. Foresta C., Garolla A., Zuccarello D. et al. Human papillomavirus found in sperm head of young adult males affects the progressive motility. // Fertil. Steril. 2010. V. 93.

№ 3. P. 802–806.

78. Foresta C., Patassini C., Bertoldo A. et al. Mechanism of human papillomavirus binding to human spermatozoa and fertilizing ability of infected spermatozoa. // PLoS One. 2011. V. 6. № 3. P. e15036.

79. Foresta C., Pizzol D., Moretti A. et al. Clinical and prognostic significance of human papillomavirus DNA in the sperm or exfoliated cells of infertile patients and subjects with risk factors. // Fertil. Steril. 2010. V. 94. № 5.P. 1723–1727.

80. Franco E.L., Duarte-Franco E., Ferenczy A. Cervical cancer: epidemiology, prevention and the role of human papillomavirus infection. // CMAJ. 2001. V. 164.

№ 7. P. 1017–1025.

81. Fredericks B.D., Balkin A., Daniel H.W. et al. Transmission of human papillomaviruses from mother to child. // Aust. N. Z. J. Obstet. Gynaecol. 1993.V. 33.

№ 1.P. 30–32.

82. Freitas A.C., Mariz F.C., Silva M.A.et al.Human papillomavirus vertical transmission: review of current data.//Clin. Infect. Dis. 2013. V. 56. № 10.P.1451–1456.

83. Garolla A., Pizzol D., Foresta C. The role of human papillomavirus on sperm function. // Curr. Opin. Obstet. Gynecol. 2011. V. 23. № 4. P. 232–237.

84. Gillet E., Meys J.F., Verstraelen H. et al. Bacterial vaginosis is associated with uterine cervical human papillomavirus infection: a meta-analysis. // BMC Infect. Dis. 2011.V. 11. № 1. P. 10.

85. Giovannelli L., Migliore M.C., Capra G. et al. Penile, urethral, and seminal sampling for diagnosis of human papillomavirus infection in men. // J. Clin. Microbiol. 2007. V. 45. № 1.P. 248–251.

86. Gomez L.M., Ma Y., Ho C. et al. Placental infection with human papillomavirus is associated with spontaneous preterm delivery. // Hum. Reprod. 2008. V. 23. № 3. P. 709–715.

87. Griffiths T.R., Mellon J.K. Human papillomavirus and urological tumours: II. Role in bladder, prostate, renal and testicular cancer. // BJU Int. 2000.V. 85. № 2. P. 211–217.

88. Hajek E.F. Contribution to the etiology of laryngeal papilloma in children. // J. Laryngol. Otol. 1956. V. 70. № 3. P. 166–168.

89. Hamouda T., Freij M.A., Saleh M. Management of genital warts in pregnancy. Clin Exp Obstet Gynecol. 2012. №39(2). P.242-244.

90. Handley J., Dinsmore W. Treatment of anogenital warts. Review J European Acad Dermatol Venerol 1994.№ 3.P.251-265.

91. Heinrich P.C., Castell J. V, Andus T. Interleukin-6 and the acute phase response.

// Biochem. J. 1990.V. 265. № 3. P. 621–636.

92. Hellberg D., Nilsson S. IVF and HPV. // Fertil. Steril. 2007. V. 87. № 6.P.1498

93. Henneberg A.A., Patton W.C., Jacobson J.D. et al. Human papilloma virus DNA exposure and embryo survival is stage-specific. // J. Assist. Reprod. Genet. 2006. V. 23.

№ 6. P. 255–259.

94. Hermonat P.L., Han L., Wendel P.J. et al. Human papillomavirus is more prevalent in first trimester spontaneously aborted products of conception compared to elective specimens. // Virus Genes. 1997.V.14. № 1.P. 13–17.

95. Hermonat P.L., Kechelava S., Lowery C.L. et al.. Trophoblasts are the preferential target for human papilloma virus infection in spontaneously aborted products of conception. // Hum. Pathol. 1998.V. 29. № 2. P. 170–174.

96. Hesselink A.T., Berkhof J., Heideman D.A. et al. High-risk human papillomavirus DNA load in a population-based cervical screening cohort in relation to the detection of high-grade cervical intraepithelial neoplasia and cervical cancer // Int J Cancer. 2009.№124.P.381.

97. Hubbert N.L., Sedman S.A., Schiller J.T. Human papillomavirus type 16 E6 increases the degradation rate of p53 in human keratinocytes. // J. Virol. 1992.V.66.

№ 10. P. 6237–6241.

98. Hunter M.I., Monk B.J., Tewari K.S. Cervical neoplasia in pregnancy. Part 1: screening and management of preinvasive disease. // Am. J. Obstet. Gynecol. 2008. V.199. № 1. P. 3–9.

99. Kaye J.N., Cason J., Pakarian F.B. et al. Viral load as a determinant for transmission of human papillomavirus type 16 from mother to child. // J. Med. Virol. 1994. V. 44. № 4.P. 415–421.

100. Khan M., Castle P. E., Lorincz A. T. et al. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of typespecific HPV testing in clinical practice. J Natl Cancer Inst. 2005.№97.P.1072 – 1079.

101. Kidd P. Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease.//Altern. Med. Rev. -2003 Aug. - Vol. 8(3). - Р.223-246.

102. Kj?r S., Frederiksen K., Munk C. et al. Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence. // J. Natl. Cancer Inst. 2010. V. 102. № 19. P. 1478–1488.

103. Kjaer S.K., Chackerian B., van den Brule A.J. High-risk human papillomavirus is sexually transmitted: evidence from a follow-up study of virgins starting sexual activity (intercourse). // Cancer Epidemiol. Biomarkers Prev. 2001.V.10. № 2. С.101–106.

104. Koch A., Hansen S.V., Nielsen N.M. et al. HPV detection in children prior to sexual debut. // Int. J. Cancer. 1997.V.73. № 5.P.621–624.

105. Kohan S., Beckman E.M., Bigelow B. et al. The role of colposcopy in the management of cervical intraepithelial neoplasia during pregnancy and postpartum. // J. Reprod. Med. 1980. V. 25. № 5. P. 279–284.

106. Kŭlvachev Z., Draganov P., Minkov L. HPV and spontaneous abortion: results from a virological study Akush Ginekol (Sofiia). 2007.№46(6).P.8-12

107. Lacour D.E., Trimble C. Human papillomavirus in infants: transmission, prevalence, and persistence. // J. Pediatr. Adolesc. Gynecol. 2012. V. 25. № 2. P. 93–97.

108. Lai C.H., Hsueh S., Lin C.Y. et al. Human papillomavirus in benign and malignant ovarian and endometrial tissues. // Int. J. Gynecol. Pathol. 1992.V.11. № 3. P. 210–215.

109. Lai Y.M., Yang F.P., Pao C.C. Human papillomavirus deoxyribonucleic acid and ribonucleic acid in seminal plasma and sperm cells. // Fertil. Steril. 1996.V. 65. № 5. P.1026–1030.

110. Laudadio J. Human papillomavirus detection: testing methodologies and their clinical utility in cervical cancer screening. // Adv. Anat. Pathol. 2013.V.20. № 3. P.158–167.

111. Lindsey C.L., Almeida M.E., Vicari C.F. et al. Bovine papillomavirus DNA in milk, blood, urine, semen, and spermatozoa of bovine papillomavirus-infected animals.

// Genet. Mol. Res. 2009.V. 8. № 1. P. 310–318.

112. Louie K.S., Castellsague X., de Sanjose S. et al. Smoking and passive smoking in cervical cancer risk: pooled analysis of couples from the IARC multicentric case-control studies. Cancer Epidemiol Biomarkers Prev. 2011. №20(7). P.1379-1390.

113. Luks S., Simon R.A., Lawrence W.D. Arias-Stella reaction of the cervix: The enduring diagnostic challenge. // Am. J. Case Rep. 2012. V. 13. P. 271–275.

114. Lundqvist M., Westin C., Lundkvist O. et al. Cytologic screening and human papilloma virus test in women undergoing artificial fertilization. // Acta Obstet. Gynecol. Scand.2002.V. 81. № 10. P. 949–53.

115. Maluf M., Perin P. HPV e gestação // Brazil Press, 2005. P. 193–225.

116. Marcoux D., Nadeau K., McCuaig C. et al. Marcoux D. и др. Pediatric anogenital warts: a 7-year review of children referred to a tertiary-care hospital in Montreal, Canada. // Pediatr. Dermatol. 2006. V. 23. № 3. P. 199–207.

117. Marinho-Dias J., Sousa H. Cytomegalovirus infection and cervical cancer: from past doubts to present questions. // Acta Med. Port. 2013. V. 26. № 2. P. 154–60.

118. Massad L.S., Einstein M.H., Huh W.K. et al. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors.

// J. Low. Genit. Tract Dis. 2013. V. 17. № 5 Suppl 1. P. S1–S27.

119. Matovina M., Husnjak K., Milutin N. et al. Possible role of bacterial and viral infections in miscarriages. // Fertil. Steril. 2004. V. 81. № 3. P. 662–669.

120. Matsumoto K., Oki A, Furuta R et al. Tobacco smoking and regression of low- grade cervical abnormalities.// Cancer Sci. 2010.№101(9).P.2065-2073.

121. McBride A.A., Romanczuk H., Howley P.M. The papillomavirus E2 regulatory proteins. // J. Biol. Chem. 1991. V. 266. № 28. P. 18411–18414.

122. McIntyre-Seltman K., Lesnock J.L. Cervical cancer screening in pregnancy. // Obstet. Gynecol. Clin. North Am. 2008. V. 35. № 4. P. 645–658.

123. Medeiros L.R., Ethur A.B., Hilgert J.B. et al. Vertical transmission of the human papillomavirus: a systematic quantitative review. // Cad. Saude Publica. 2005. V. 21.

№ 4. P. 1006–1015.

124. Monroy O.L., Aguilar C., Lizano M. et al. Prevalence of human papillomavirus genotypes, and mucosal IgA anti-viral responses in women with cervical ectopy. // J. Clin. Virol. 2010. V. 47. № 1. P. 43–48.

125. Moore K., de Waal Malefyt R., Coffman R.L. Interleukine-10 and interleukine-10 receptor // Ann. Rev. Immunol. 2001. V. 19. P. 683-765.

126. Morimura Y., Fujimori K., Soeda S. et al. Cervical cytology during pregnancy-- comparison with non-pregnant women and management of pregnant women with abnormal cytology. // Fukushima J. Med. Sci. 2002. V. 48. № 1. P. 27–37.

127. Mota F., Calder V., Rutault K. et al. Characterization of soluble factors from cultures of premalignant cervical epithelium. // Eur. J. Gynaecol. Oncol. 1999. V. 20.

№ 4. P. 262–267.

128. Mota F., Rayment N., Chong S. et al. The antigen-presenting environment in normal and human papillomavirus (HPV)-related premalignant cervical epithelium. // Clin. Exp. Immunol. 1999. V. 116. № 1. P. 33–40.

129. Motevaseli E., Shirzad M., Akrami S.M. et al. Normal and tumour cervical cells respond differently to vaginal lactobacilli, independent of pH and lactate. // J. Med. Microbiol. 2013. Т. 62. № Pt 7. P. 1065–1072.

130. Myhre A.K., Dalen A., Berntzen K. et al. Anogenital human papillomavirus in non-abused preschool children. // Acta Paediatr. 2003. V. 92. № 12. P. 1445–1452.

131. Natphopsuk S., Settheetham-Ishida W., Sinawat S et al. Risk factors for cervical cancer in northeastern Thailand: detailed analyses of sexual and smoking behavior.// Asian Pac J Cancer Prev. 2012.№13(11).P.5489-5495.

132. Nguyen C., Montz F.J., Bristow R.E. Management of stage I cervical cancer in pregnancy. // Obstet. Gynecol. Surv. 2000. V. 55. № 10. P. 633–643.

133. Pakarian F., Kaye J., Cason J. et al. Cancer associated human papillomaviruses: perinatal transmission and persistence. // Br. J. Obstet. Gynaecol. 1994. V. 101. № 6.P. 514–517.

134. Park H., Lee S.W., Lee I.H. et al. Rate of vertical transmission of human papillomavirus from mothers to infants: relationship between infection rate and mode of delivery.// Virol J. 2012. Apr V.12.№9.P.80.

135. Passmore J.A., Marais D.J., Sampson C. et al. Cervicovaginal, oral, and serum IgG and IgA responses to human papillomavirus type 16 in women with cervical intraepithelial neoplasia. // J. Med. Virol. 2007. V. 79. № 9. P. 1375–1380.

136. Perino A., Giovannelli L., Schillaci R. et al. Human papillomavirus infection in couples undergoing in vitro fertilization procedures: impact on reproductive outcomes.

// Fertil. Steril. 2011. V. 95. № 5. P. 1845–1848.

137. Pimenta J., Galindo C., Jenkins D. et al. Estimate of the global burden of cervical adenocarcinoma and potential impact of prophylactic human papillomavirus vaccination. // BMC Cancer. 2013. V. 13. P. 553.

138. Plummer M., Peto J, Franceschi S et al. Time since first sexual intercourse and the risk of cervical cancer.// Int J Cancer. 2012. V.130.№11.P.2638-2644.

139. Puranen M., Yliskoski M., Saarikoski S. et al.. Vertical transmission of human papillomavirus from infected mothers to their newborn babies and persistence of the virus in childhood. // Am. J. Obstet. Gynecol. 1996. V. 174. № 2. P. 694–699.

140. Puranen M.H. Yliskoski MH, Saarikoski SV et al. Exposure of an infant to cervical human papillomavirus infection of the mother is common. // Am. J. Obstet. Gynecol. 1997. V. 176. № 5. P. 1039–1045.

141. Raghupathy R., Kalinka J. Cytokine imbalance in pregnancy complications and its modulation.// Front Biosci. 2008.№13.P.985-994.

142. Rintala M.A., Grenman S.E., Pollänen P.P. et al. Detection of high-risk HPV DNA in semen and its association with the quality of semen. // Int. J. STD AIDS. 2004. V. 15. № 11. P. 740–743.

143. Rintala M.A., Grenman S.E., Puranen M.H. et al. Transmission of high-risk human papillomavirus (HPV) between parents and infant: a prospective study of HPV in families in Finland. // J. Clin. Microbiol. 2005. V. 43. № 1. P. 376–381.

144. Rintala M.A., Pollänen P.P., Nikkanen V.P. Human papillomavirus DNA is found in the vas deferens. // J. Infect. Dis. 2002. V. 185. № 11. P. 1664–1667.

145. Rogovskaya S.I., Shabalova I.P., Mikheeva I.V. et al. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western Countries of the former Soviet Union, Caucasus Region and Central Asia. ICO Monograph Comprehensive control of human papillomavirus infections and related diseases in the central and Eastren Europe and Central Asia region Vaccine Vol. 31, Supp.7,2013.

146. Rombaldi R.L., Serafini E.P., Mandelli J. et al. Perinatal transmission of human papilomavirus DNA. // Virol. J. 2009. V. 6. P. 83.

147. Roperto S., Borzacchiello G., Esposito I. et al. Productive infection of bovine papillomavirus type 2 in the placenta of pregnant cows affected with urinary bladder tumors. // PLoS One. 2012. V. 7. № 3. e33569.

148. Roperto S., Comazzi S., Ciusani E. et al. PBMCs are additional sites of productive infection of bovine papillomavirus type 2. // J. Gen. Virol. 2011. V. 92. № Pt 8. P. 1787–1794.

149. Roset Bahmanyar E., Paavonen J., Naud P. et al. Prevalence and risk factors for cervical HPV infection and abnormalities in young adult women at enrolment in the multinational PATRICIA trial. Gynecol Oncol. 2012 Dec.V.127.№3.P.440-450.

150. Rozmus-Warcholińska W., Loch T., Czuba B. et al. Genital warts associated with HPV infection during II and III trimester of pregnancy-a case report and analysis of treatment options Ginekol Pol. 2007.V.78.№11.P.888-891.

151. Russomano F., Reis A., de Camargo M.J. et al Efficacy in treatment of subclinical cervical HPV infections without intraepithelial neoplasia: systematic review. Sao Paulo Med. J. 2000; 118(4): 109-15.

152. Saini V., Arora S., Yadav A. Cytokines in recurrent pregnancy loss.//Clin Chim Acta. 2011. Apr 11.V.412(9-10).P.702-708.

153. Sarkola M.E., Grenman S.E., Rintala M.A. et al. Human papillomavirus in the placenta and umbilical cord blood. // Acta Obstet. Gynecol. Scand. 2008. V. 87. № 11. P.1181–1188.

154. Saslow D., Solomon D., Lawson H.W. et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer.

// J. Low. Genit. Tract Dis. 2012. V. 16. № 3. P. 175–204.

155. Sedlacek T.V., Lindheim S., Eder C. et al. Mechanism for human papillomavirus transmission at birth. // Am. J. Obstet. Gynecol. 1989.V.161. № 1. P. 55–59.

156. Shi T.Y., Zhu M.L., He J. et al. Polymorphisms of the Interleukin 6 gene contribute to cervical cancer susceptibility in Eastern Chinese women. // Hum. Genet. 2013. V. 132. № 3. P. 301–312.

157. Siebers A.G., Klinkhamer P.J., Grefte J.M. et al. Comparison of liquid-based cytology with conventional cytology for detection of cervical cancer precursors: a randomized controlled trial. // JAMA. 2009. V. 302. № 16. P. 1757–1764.

158. Silva C.S. da , Adad S.J., Hazarabedian de Souza M.A. et al. Increased frequency of bacterial vaginosis and Chlamydia trachomatis in pregnant women with human papillomavirus infection. // Gynecol. Obstet. Invest. 2004. V. 58. № 4. P. 189–193.

159. Silva M.A., Pontes N.E., Da Silva K.M. et al. Detection of bovine papillomavirus type 2 DNA in commercial frozen semen of bulls (Bos taurus). // Anim. Reprod. Sci. 2011. V. 129. № 3-4. P. 146–151.

160. Silverberg M.J. Thorsen P, Lindeberg H et al. Condyloma in pregnancy is strongly predictive of juvenile-onset recurrent respiratory papillomatosis. // Obstet. Gynecol. 2003. V. 101. № 4. P. 645–52.

161. Skoczyński M., Goździcka-Jozefiak A., Kwaśniewska A. Prevalence of human papillomavirus in spontaneously aborted products of conception. // Acta Obstet. Gynecol. Scand. 2011. V. 90. № 12. P. 1402–1405.

162. Smith E.M., Parker M.A., Rubenstein L.M. et al. Evidence for vertical transmission of HPV from mothers to infants. // Infect. Dis. Obstet. Gynecol. 2010. V. 2010. P. 326-369.

163. Smith E.M., Ritchie J.M., Yankowitz J. et al. Human papillomavirus prevalence and types in newborns and parents: concordance and modes of transmission. // Sex. Transm. Dis. 2004. V. 31. № 1. P. 57–62.

164. Solomon D., Davey D., Kurman R. et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. // JAMA. 2002.V. 287. № 16.P. 2114–2119.

165. Spandorfer S., Bongiovanni A., Fasioulotis S. et al. Prevalence of cervical human papillomavirus in women undergoing in vitro fertilization and association with outcome. Fertil Steril 2006.V. 86. № 3. P. 765–767.

166. Stanley M. Pathology and epidemiology of HPV infection in females. // Gynecol. Oncol. 2010. V. 117. № 2 Suppl. P. S5–10.

167. Stevens-Simon C., Nelligan D., Breese P. et al. The prevalence of genital human papillomavirus infections in abused and nonabused preadolescent girls. // Pediatrics. 2000. V. 106. № 4. P. 645–649.

168. Stillson T., Knight A.L., Elswick R.K. The effectiveness and safety of two cervical cytologic techniques during pregnancy. // J. Fam. Pract. 1997. V. 45. № 2. P. 159–163.

169. Stonehocker J. Cervical cancer screening in pregnancy. // Obstet. Gynecol. Clin. North Am. 2013. V. 40. № 2. P. 269–82.

170. Syrjänen S. Current concepts on human papillomavirus infections in children. // APMIS. 2010. V. 118. № 6-7. P. 494–509.

171. Syrjänen S., Puranen M. Human papillomavirus infections in children: the potential role of maternal transmission. // Crit. Rev. Oral Biol. Med. 2000. V. 11. № 2. P. 259–274.

172. Tarka A., Szczepańska M., Raczyńska D. et al. Risk factors and frequency of occurrence of HPV DNA of high oncogenic types in paraepidermal epithelium cells of the uterine cervix, in the trophoblast, and in the peripheral blood of pregnant patients. Ginekol Pol 2008. №79. P.871–876.

173. Tenti P. Zappatore R, Migliora P et al. Perinatal transmission of human papillomavirus from gravidas with latent infections. // Obstet. Gynecol. 1999. V. 93.

№ 4. P. 475–479.

174. The 1988 Bethesda System for reporting cervical/vaginal cytologic diagnoses: developed and approved at the National Cancer Institute workshop in Bethesda, MD, December 12-13, 1988. // Diagn. Cytopathol. 1989. V. 5. № 3. P. 331–334.

175. Tjiong MY, van der Vange N, ten Kate FJ Tjiong M.Y. и др. Increased IL-6 and IL-8 levels in cervicovaginal secretions of patients with cervical cancer. // Gynecol. Oncol. 1999.V. 73. № 2. P. 285–291.

176. Tseng C.J., Liang CC, Soong YK, et al. Perinatal transmission of human papillomavirus in infants: relationship between infection rate and mode of delivery. // Obstet. Gynecol. 1998. V. 91. № 1. P. 92–96.

177. Ueda Y., Enomoto T., Miyatake T. et al. Postpartum outcome of cervical intraepithelial neoplasia in pregnant women determined by route of delivery. Reprod Sci 2009.V.16.№11.P.1034—1039.

178. Vernon S.D., Unger E.R., Williams D. Comparison of human papillomavirus detection and typing by cycle sequencing, line blotting, and hybrid capture. // J. Clin. Microbiol. 2000. V. 38. № 2. P. 651–655.

179. Villiers E.M. de, Fauquet C., Broker T.R. et al. Classification of papillomaviruses. Virology 2004.V. 324.№1.P. 17–27.

180. Wang Y, Wang C, Qiao J et al. Relationship of cytopathology and cervical infection to outcome of in-vitro fertilization and embryo transfer. // Int. J. Gynaecol. Obstet. 2008. V. 101. № 1. P. 21–26.

181. Watts D.H., Koutsky L.A., Holmes K.K. et al. Low risk of perinatal transmission of human papillomavirus: results from a prospective cohort study. // Am. J. Obstet. Gynecol. 1998. V. 178. № 2. P. 365–373.

182. Werness B.A., Levine A.J., Howley P.M. Association of human papillomavirus types 16 and 18 E6 proteins with p53. // Science. 1990.V.248. № 4951. P. 76–79.

183. Wheeler C.M., Hunt W.C., Schiffman M., et al. Human papillomavirus genotypes and the cumulative 2-year risk of cervical precancer. J. Infect. Dis. 2006.

№194.P. 1291–1299.

184. WHO | Comprehensive cervical cancer control: A guide to essential practice [Электронный ресурс]. URL: http://www.who.int/cancer/publications/9241547006/en/ (дата обращения:19.04.2014).

185. WHO. Cervical cancer, human papillomavirus (HPV), and HPV vaccines. Key points for policy-makers and health professionals [Электронный ресурс].URL:http://whqlibdoc.who.int/hq/2008/WHO_RHR_08.14_eng.pdf?ua=1(дата обращения: 19.04.2014).

186. WHO. Human papillomavirus vaccines WHO position paper // Wkly. Epidemiol. Rec. 2009.V. 84. № 15. P. 118–130.

187. Winckworth L.C^., Nichol R. Question 2: do caesarean sections reduce the maternal-fetal transmission rate of human papillomavirus infection? Arch Dis Child. 2010.V.95.№1.P.70-73.

188. Winer R.L., Lee S.K., Hughes J.P. et al. Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. // Am. J. Epidemiol. 2003. V. 157. № 3. P. 218–226.

189. Woodrow N., Permezel M, Butterfield L et al. Abnormal cervical cytology in pregnancy: experience of 811 cases. // Aust. N. Z. J. Obstet. Gynaecol. 1998. V. 38.

№ 2. P. 161–165.

190. Wu Y.M,, Wang T., He Y., et al. Clinical management of cervical intraepithelial neoplasia in pregnant and postpartum women. // Arch. Gynecol. Obstet. 2014.V. 289.

№ 5. P. 1071–1077.

191. Yang W., Song Y., Lu Y.L. et al. Increased expression of programmed death (PD)-1 and its ligand PD-L1 correlates with impaired cell-mediated immunity in high- risk human papillomavirus-related cervical intraepithelial neoplasia. // Immunology. 2013. V. 139. № 4. P. 513–522.

192. You H. Liu Y, Agrawal N et al. Infection, replication, and cytopathology of human papillomavirus type 31 in trophoblasts. // Virology. 2003.V. 316.

№ 2. P. 281–289.

193. Younes A.S., Csire M., Kapusinszky B. et al. Heterogeneous pathways of maternal-fetal transmission of human viruses (review). // Pathol. Oncol. Res. 2009. V.15. № 3.P.451–465.

194. Zenclussen A.C. Adaptive immune responses during pregnancy.//Am J Reprod Immunol. 2013.V.69.№4.P.291-303.

195. Zuo Z., Goel S., Carter J.E. Association of cervical cytology and HPV DNA status during pregnancy with placental abnormalities and preterm birth. // Am. J. Clin. Pathol. 2011. V. 136. № 2. P. 260–265.

196. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. // Nat. Rev. Cancer. 2002. V. 2. № 5. P. 342–50.